US equities |
NVDA $176.43 ▼-5.47% AMD $503.02 ▲+12.02% MU $726.74 ▲+5.32% SPCX $141.05 ▲+5.05% SNDK $882.16 ▲+5.64% AMZN $268.05 ▲+3.37% TSLA $376.95 ▲+5.23% META $642.34 ▲+5.28%
FinancialContent

Orthofix Medical Inc. - Common Stock (NQ:OFIX)

7.190 -0.680 (-8.64%)
Delayed Quote Updated: 1:16 PM EST, Nov 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Orthofix Medical Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Orthofix Reports Third Quarter 2026 Results and Revises Full-Year 2026 Guidance
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix to Report Third Quarter 2026 Financial Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix to Participate in Upcoming Investor Conferences
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix to Report Second Quarter 2026 Financial Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix to Participate in Upcoming Investor Conferences
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Expands Pediatric Limb Reconstruction Portfolio with New FITBONE™ Innovation at POSNA 2026 Annual Meeting
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Orthofix Medical, Inc. - OFIX
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Orthofix to Report First Quarter 2026 Financial Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Orthofix Medical, Inc. - OFIX
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Orthofix Realigns Spine Leadership to Strengthen Focus and Execution
From Orthofix Medical Inc.
Via Business Wire
News headline image
Halper Sadeh LLC Encourages Orthofix Medical Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
OFIX Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Orthofix Medical Inc. – OFIX
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
Orthofix Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Orthofix Medical, Inc. – OFIX
From Rosen Law Firm
Via Business Wire
News headline image
Orthofix Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix to Participate in Upcoming Investor Conferences
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix to Report Fourth Quarter and Full-Year 2025 Financial Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Reports Third Quarter 2025 Financial Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix to Participate in Upcoming Investor Conferences
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix to Report Third Quarter 2025 Financial Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Orthofix Reports Second Quarter 2025 Financial Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix to Participate at Canaccord Genuity 45th Annual Growth Conference
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix to Report Second Quarter 2025 Financial Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces Global Commercial Launch of the TrueLok Elevate Transverse Bone Transport System
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Reports First Quarter 2025 Financial Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix to Report First Quarter 2025 Financial Results
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Receives 510(k) Clearance and CE Mark for TrueLok Elevate Transverse Bone Transport System
From Orthofix Medical Inc.
Via Business Wire
News headline image
Orthofix Announces Appointment of Vickie Capps to Board of Directors
From Orthofix Medical Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >